Cargando…
Machine learning in the development of targeting microRNAs in human disease
A microRNA is a small, single-stranded, non-coding ribonucleic acid that plays a crucial role in RNA silencing and can regulate gene expression. With the in-depth study of miRNA in development and disease, miRNA has become an attractive target for novel therapeutic strategies. Exploring miRNA target...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845262/ https://www.ncbi.nlm.nih.gov/pubmed/36685965 http://dx.doi.org/10.3389/fgene.2022.1088189 |
_version_ | 1784870858989240320 |
---|---|
author | Luo, Yuxun Peng, Li Shan, Wenyu Sun, Mengyue Luo, Lingyun Liang, Wei |
author_facet | Luo, Yuxun Peng, Li Shan, Wenyu Sun, Mengyue Luo, Lingyun Liang, Wei |
author_sort | Luo, Yuxun |
collection | PubMed |
description | A microRNA is a small, single-stranded, non-coding ribonucleic acid that plays a crucial role in RNA silencing and can regulate gene expression. With the in-depth study of miRNA in development and disease, miRNA has become an attractive target for novel therapeutic strategies. Exploring miRNA targeting therapy only through experiments is expensive and laborious, so it is essential to develop novel and efficient computational methods to narrow down the search. Recent advances in machine learning applied in biomedical informatics provide opportunities to explore miRNA-targeting drugs, thus promoting miRNA therapeutics. This review provides an overview of recent advancements in miRNA targeting therapeutic using machine learning. First, we mainly describe the basics of predicting miRNA targeting drugs, including pharmacogenomic data resources and data preprocessing. Then we present primary machine learning algorithms and elaborate their application in discovering relationships among miRNAs, drugs, and diseases. Along with the progress of miRNA targeting therapeutics, we finally analyze and discuss the current challenges and opportunities that machine learning confronts. |
format | Online Article Text |
id | pubmed-9845262 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98452622023-01-19 Machine learning in the development of targeting microRNAs in human disease Luo, Yuxun Peng, Li Shan, Wenyu Sun, Mengyue Luo, Lingyun Liang, Wei Front Genet Genetics A microRNA is a small, single-stranded, non-coding ribonucleic acid that plays a crucial role in RNA silencing and can regulate gene expression. With the in-depth study of miRNA in development and disease, miRNA has become an attractive target for novel therapeutic strategies. Exploring miRNA targeting therapy only through experiments is expensive and laborious, so it is essential to develop novel and efficient computational methods to narrow down the search. Recent advances in machine learning applied in biomedical informatics provide opportunities to explore miRNA-targeting drugs, thus promoting miRNA therapeutics. This review provides an overview of recent advancements in miRNA targeting therapeutic using machine learning. First, we mainly describe the basics of predicting miRNA targeting drugs, including pharmacogenomic data resources and data preprocessing. Then we present primary machine learning algorithms and elaborate their application in discovering relationships among miRNAs, drugs, and diseases. Along with the progress of miRNA targeting therapeutics, we finally analyze and discuss the current challenges and opportunities that machine learning confronts. Frontiers Media S.A. 2023-01-04 /pmc/articles/PMC9845262/ /pubmed/36685965 http://dx.doi.org/10.3389/fgene.2022.1088189 Text en Copyright © 2023 Luo, Peng, Shan, Sun, Luo and Liang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Genetics Luo, Yuxun Peng, Li Shan, Wenyu Sun, Mengyue Luo, Lingyun Liang, Wei Machine learning in the development of targeting microRNAs in human disease |
title | Machine learning in the development of targeting microRNAs in human disease |
title_full | Machine learning in the development of targeting microRNAs in human disease |
title_fullStr | Machine learning in the development of targeting microRNAs in human disease |
title_full_unstemmed | Machine learning in the development of targeting microRNAs in human disease |
title_short | Machine learning in the development of targeting microRNAs in human disease |
title_sort | machine learning in the development of targeting micrornas in human disease |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845262/ https://www.ncbi.nlm.nih.gov/pubmed/36685965 http://dx.doi.org/10.3389/fgene.2022.1088189 |
work_keys_str_mv | AT luoyuxun machinelearninginthedevelopmentoftargetingmicrornasinhumandisease AT pengli machinelearninginthedevelopmentoftargetingmicrornasinhumandisease AT shanwenyu machinelearninginthedevelopmentoftargetingmicrornasinhumandisease AT sunmengyue machinelearninginthedevelopmentoftargetingmicrornasinhumandisease AT luolingyun machinelearninginthedevelopmentoftargetingmicrornasinhumandisease AT liangwei machinelearninginthedevelopmentoftargetingmicrornasinhumandisease |